Header list of 2g57.pdb file
Complete list - 9 20 Bytes
HEADER ONCOPROTEIN 22-FEB-06 2G57
TITLE STRUCTURE OF THE PHOSPHORYLATION MOTIF OF THE ONCOGENIC PROTEIN BETA-
TITLE 2 CATENIN RECOGNIZED BY A SELECTIVE MONOCLONAL ANTIBODY
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BETA-CATENIN;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: RESIDUES 19-44;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS.
KEYWDS BETA-CATENIN ONCOGENIC PROTEIN, P-BETA-CATENIN PHOSPHORYLATED
KEYWDS 2 PEPTIDE, EPITOPE MAPPING, ANTIBODY, P-BETA-CATENIN-ANTIBODY COMPLEX,
KEYWDS 3 STD-NMR, TRNOESY, RESTRAINED MOLECULAR DYNAMICS, BOUND STRUCTURE,
KEYWDS 4 BINDING FRAGMENT, ONCOPROTEIN
EXPDTA SOLUTION NMR
NUMMDL 10
AUTHOR S.MEGY,G.BERTHO,J.GHARBI-BENAROUS,F.BALEUX,R.BENAROUS,J.P.GIRAULT
REVDAT 4 09-MAR-22 2G57 1 REMARK SEQADV LINK
REVDAT 3 24-FEB-09 2G57 1 VERSN
REVDAT 2 10-OCT-06 2G57 1 JRNL
REVDAT 1 28-MAR-06 2G57 0
JRNL AUTH S.MEGY,G.BERTHO,J.GHARBI-BENAROUS,F.BALEUX,R.BENAROUS,
JRNL AUTH 2 J.P.GIRAULT
JRNL TITL STD AND TRNOESY NMR STUDIES FOR THE EPITOPE MAPPING OF THE
JRNL TITL 2 PHOSPHORYLATION MOTIF OF THE ONCOGENIC PROTEIN BETA-CATENIN
JRNL TITL 3 RECOGNIZED BY A SELECTIVE MONOCLONAL ANTIBODY
JRNL REF FEBS LETT. V. 580 5411 2006
JRNL REFN ISSN 0014-5793
JRNL PMID 16996060
JRNL DOI 10.1016/J.FEBSLET.2006.08.084
REMARK 2
REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : XWINNMR, ARIA 1.2
REMARK 3 AUTHORS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2G57 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-FEB-06.
REMARK 100 THE DEPOSITION ID IS D_1000036702.
REMARK 210
REMARK 210 EXPERIMENTAL DETAILS
REMARK 210 EXPERIMENT TYPE : NMR
REMARK 210 TEMPERATURE (KELVIN) : 278
REMARK 210 PH : 7.4
REMARK 210 IONIC STRENGTH : 20MM
REMARK 210 PRESSURE : 1 ATM
REMARK 210 SAMPLE CONTENTS : 1MM P-BETA-CAT PEPTIDE WITH
REMARK 210 0.01MM ANTIBODY; 20MM PHOSPHATE
REMARK 210 BUFFERED SALINE(PH 7.4); 15MM
REMARK 210 SODIUM AZIDE; 90% H2O, 10% D2O
REMARK 210
REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY
REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ
REMARK 210 SPECTROMETER MODEL : AVANCE
REMARK 210 SPECTROMETER MANUFACTURER : BRUKER
REMARK 210
REMARK 210 STRUCTURE DETERMINATION.
REMARK 210 SOFTWARE USED : FELIX
REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED
REMARK 210 ANNEALING, TORSION ANGLE DYNAMICS
REMARK 210
REMARK 210 CONFORMERS, NUMBER CALCULATED : 20
REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10
REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST
REMARK 210 RESTRAINT VIOLATIONS
REMARK 210
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1
REMARK 210
REMARK 210 REMARK: NULL
REMARK 215
REMARK 215 NMR STUDY
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION
REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON
REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 1 GLN A 28 -18.65 -142.44
REMARK 500 1 HIS A 36 13.39 58.31
REMARK 500 1 SEP A 37 15.75 58.49
REMARK 500 2 THR A 41 38.51 -156.26
REMARK 500 2 ALA A 43 -51.00 -157.20
REMARK 500 3 GLN A 28 -31.84 -132.69
REMARK 500 3 ASP A 32 -74.30 -73.46
REMARK 500 3 SEP A 33 -80.87 60.99
REMARK 500 3 THR A 41 32.11 -151.07
REMARK 500 3 ALA A 43 77.18 51.83
REMARK 500 4 ILE A 35 74.35 55.75
REMARK 500 4 THR A 41 34.69 -147.80
REMARK 500 4 ALA A 43 88.01 57.00
REMARK 500 5 ILE A 35 -37.77 -130.41
REMARK 500 5 HIS A 36 42.86 -81.38
REMARK 500 5 ALA A 39 -8.52 71.68
REMARK 500 5 THR A 41 29.68 173.90
REMARK 500 5 THR A 42 8.98 59.21
REMARK 500 5 ALA A 43 80.30 50.08
REMARK 500 6 SEP A 37 17.06 56.23
REMARK 500 7 HIS A 36 10.99 58.43
REMARK 500 7 ALA A 43 -50.67 -171.06
REMARK 500 8 SEP A 33 12.79 -145.39
REMARK 500 8 HIS A 36 -2.85 67.57
REMARK 500 8 THR A 40 24.75 -147.30
REMARK 500 8 THR A 42 31.22 -142.56
REMARK 500 9 GLN A 28 -10.61 -143.57
REMARK 500 9 THR A 41 26.95 -169.53
REMARK 500 9 ALA A 43 76.02 46.99
REMARK 500 10 GLN A 28 -1.01 -144.03
REMARK 500 10 ILE A 35 97.07 68.87
REMARK 500 10 HIS A 36 104.03 51.67
REMARK 500 10 SEP A 37 -9.85 -54.79
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE A 18
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 45
DBREF 2G57 A 19 44 UNP P35222 CTNB1_HUMAN 19 44
SEQADV 2G57 SEP A 33 UNP P35222 SER 33 MODIFIED RESIDUE
SEQADV 2G57 SEP A 37 UNP P35222 SER 37 MODIFIED RESIDUE
SEQRES 1 A 28 ACE LYS ALA ALA VAL SER HIS TRP GLN GLN GLN SER TYR
SEQRES 2 A 28 LEU ASP SEP GLY ILE HIS SEP GLY ALA THR THR THR ALA
SEQRES 3 A 28 PRO NH2
MODRES 2G57 SEP A 33 SER PHOSPHOSERINE
MODRES 2G57 SEP A 37 SER PHOSPHOSERINE
HET ACE A 18 6
HET SEP A 33 14
HET SEP A 37 14
HET NH2 A 45 3
HETNAM ACE ACETYL GROUP
HETNAM SEP PHOSPHOSERINE
HETNAM NH2 AMINO GROUP
HETSYN SEP PHOSPHONOSERINE
FORMUL 1 ACE C2 H4 O
FORMUL 1 SEP 2(C3 H8 N O6 P)
FORMUL 1 NH2 H2 N
LINK C ACE A 18 N LYS A 19 1555 1555 1.33
LINK C ASP A 32 N SEP A 33 1555 1555 1.33
LINK C SEP A 33 N GLY A 34 1555 1555 1.33
LINK C HIS A 36 N SEP A 37 1555 1555 1.33
LINK C SEP A 37 N GLY A 38 1555 1555 1.33
LINK C PRO A 44 N NH2 A 45 1555 1555 1.33
SITE 1 AC1 1 VAL A 22
SITE 1 AC2 1 PRO A 44
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000
MODEL 1
Complete list - 9 20 Bytes